Mohammadieh, Anna Mary http://orcid.org/0000-0002-3217-5409
Dissanayake, Hasthi U.
Sutherland, Kate
Ucak, Seren
De Chazal, Philip
Cistulli, Peter A.
Funding for this research was provided by:
Ramsay Research and Teaching Fund
University of Sydney
Article History
Received: 20 January 2022
Accepted: 24 March 2022
First Online: 9 April 2022
Declarations
:
: Approval for this trial was obtained from the Northern Sydney Local Health District Human Research Ethics Committee (HREC/16/HAWKE/25) and the North Shore Private Hospital Ethics Committee (approval number 2016–012). The study was performed in accordance with the 1964 Helsinki Declaration and its later amendments. The trial was registered with the Australian New Zealand Clinical Trials Registry (ANZCTR): 12616001016426.
: All the patients gave their informed written consent to participate in the study.
: AMM reports in-kind support from Resmed Pty Ltd, Australia and Somnomed Australia.PAC has an appointment to an endowed academic Chair at the University of Sydney that was created from ResMed funding. He has received research support from ResMed, SomnoMed, Zephyr Sleep Technologies and Bayer. He is a consultant/adviser to Zephyr Sleep Technologies, ResMed, SomnoMed and Signifier Medical Technologies. He has a pecuniary interest in SomnoMed related to a previous role in R&D (2004).KS reports in-kind support from SomnoMed for a previous investigator-initiated research study. PdeC holds an endowed academic chair at the University of Sydney, established through funding from ResMed and has received research support from ResMed, SpaceLabs and Somnomed. HUD has received funding from the ResMed Foundation.